ResMed Inc (RMD)

Debt-to-capital ratio

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	5,546,130	5,253,010	5,195,030	4,864,040	4,629,920	4,481,850	4,250,380	4,129,900	3,932,510	3,738,130	3,432,890	3,360,750	3,278,800	3,145,840	3,026,050	2,885,680	2,709,230	2,864,980	2,678,860	2,497,030
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

March 31, 2025 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $5,546,130K)
= 0.00

The debt-to-capital ratio for ResMed Inc., as presented in the provided data, has remained consistently at zero across all recorded reporting periods, from June 30, 2020, through March 31, 2025. This indicates that the company has not reported any debt liabilities relative to its total capital during this timeframe. Such a persistent zero ratio suggests that ResMed Inc. has relied exclusively on equity financing or internally generated funds for its capital structure, without leveraging debt instruments. Consequently, the company's capital structure appears to be entirely equity-based, which could imply a conservative financial strategy with minimal or no leverage, reducing financial risk associated with debt obligations. This stable and debt-free profile is notable and may influence investor perception regarding the company's financial stability and risk profile.